Medicalsystem Biotechnology Co., Ltd. (300439.SZ)

CNY 11.16

(-0.36%)

Market Cap (In CNY)

4.27 Billion

Revenue (In CNY)

1.88 Billion

Net Income (In CNY)

256.55 Million

Avg. Volume

3.96 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
7.28-13.24
PE
-
EPS
-
Beta Value
0.386
ISIN
CNE100001Z25
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Ji Hua Zou
Employee Count
-
Website
https://www.nbmedicalsystem.com
Ipo Date
2015-04-22
Details
Medicalsystem Biotechnology Co., Ltd. provides clinical diagnostics reagents and instruments in China. The company offers PCR kit, antibody test kit, antigen test kit, and nucleic acid reagent for COVID-19; automated biochemistry analyzers and bio reagents; hematology analyzers; urine analyzers; glycated hemoglobin analyzer; POCT; and chemiluminescene immunoassay analyzers. It also provides healthcare services. The company was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name to Medicalsystem Biotechnology Co., Ltd. in January 2017. Medicalsystem Biotechnology Co., Ltd. was founded in 2003 and is based in Ningbo, China.